Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
Humatica, the leading private equity specialist advisor for portfolio organizational effectiveness, is proud to have supported HVD Partners and the Solifos AG management with the…Read more
Is your Sales Force ready for digital sales? As 2020 draws to a close, corporate leaders are looking back over the last months since COVID…Read more